The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh, Stanley B. Cohen, Karel Pavelka, Ronald van Vollenhoven, John Sharp, John L. Perez, George T. Spencer-GreenТом:
54
Рік:
2006
Мова:
english
Сторінки:
12
DOI:
10.1002/art.21519
Файл:
PDF, 279 KB
english, 2006